Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 9521-9530 of 13616

Page
per page
  1. BMS 195614
    B7459 BMS 195614
    Summary: Neutral RARα selective antagonist
      <11.21 mg/mL
  2. TC-E 5006
    B7719 TC-E 5006
    Summary: γ-secretase modulator
      <49.95 mg/mL
  3. Artemether (SM-224)
    A4014 Artemether (SM-224)
    Summary: Semi-synthetic derivative of artemisinin
      insoluble in H2O; ≥15.3 mg/mL
  4. WP1066
    A4140 WP1066
     2 Citation
    Target: STAT|JAK
    Summary: JAK2/STAT3 inhibitor,cell-permeable
      insoluble in H2O; ≥17.8 mg/mL
  5. Lopinavir
    A8204 Lopinavir
    Summary: HIV protease inhibitor,highly potent
      ≥31.45 mg/mL
  6. PCI-24781 (CRA-024781)
    A4098 PCI-24781 (CRA-024781)
    Target: Histone Deacetylases (HDACs)
    Summary: Pan-HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.75 mg/mL
  7. PHA-680632
    A4122 PHA-680632
    Target: Aurora Kinases|PLK|FGFR
    Summary: Aurora kinase inhibitor,novel and potent
      ≥50.2 mg/mL
  8. Pioglitazone HCl
    A4324 Pioglitazone HCl
    Summary: PPARγ agonist
      insoluble in H2O; ≥19.65 mg/mL
  9. Cilostazol
    A4337 Cilostazol
    Summary: PDE3 inhibitor
      insoluble in H2O; ≥15.4 mg/mL
  10. VER 155008
    A4387 VER 155008
     4 Citation
    Summary: HSP 70 inhibitor,adenosine-derived
      ≥27.8 mg/mL

Items 9521-9530 of 13616

Page
per page